Heart disease remains the leading cause of death among women worldwide, yet the risk assessments guiding prevention have long missed a quiet and persistent threat: chronic inflammation. Research published in the European Heart Journal reveals that elevated inflammatory markers — particularly hsCRP — significantly raise a woman's odds of heart attack and stroke, even when every conventional risk factor appears normal. This finding invites a broader reckoning with how medicine defines danger, and how women might reclaim agency over a risk that, unlike genetics, responds meaningfully to how one l
Times of India
· Sep 16, 2025
· health
· 3 min read
High
Sourcing: Verified
Chronic inflammation emerges as overlooked heart disease risk factor in women
◉
Health & Medicine
8098 related articles
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 100% match
Blood test could predict Covid-19 mortality risk, study finds
BreakingNews.ie · 99% match
Hadassah performs world's first alpha radiation treatment for recurren…
jpost.com · 99% match
Dr. Reddy's Wins Semaglutide Approval as Novo Nordisk Patent Challenge…
NDTV Profit · 99% match
EU safety committee reviews reports of menstrual changes after mRNA CO…
CNBC · 99% match
Related Coverage
The Guardian · Aug 20
Hundreds of thousands await GCSE results as gender gap narrows to 10-year low
Hundreds of thousands of UK students received GCSE results showing overall grade improvements in 2025, with the gender g…
The Straits Times · Aug 20 Ebola spreads beyond Congo epicentre, overwhelming treatment capacityEbola cases in DRC are accelerating outside the initial Ituri epicenter, with North Kivu and Haut-Uélé provinces experie…
Science Daily · Aug 20 1,000+ genetic switches explain why women face higher autoimmune disease riskResearchers identified over 1,000 genetic switches that function differently in male and female immune cells, explaining…
News-Medical · Aug 20 Brain's Local Wiring May Buffer Cognitive Decline in Older AdultsUSC researchers found that white matter integrity helps protect cognitive function in older adults by compensating for g…
Bias & Framing
⚖
Article presents chronic inflammation as underrecognized heart disease risk in women with scientific backing, though lacks counterarguments or discussion of evidence limitations.
Bias Direction
center-left
Confidence
MED
Health awareness framing emphasizing overlooked risk factors and proactive management; positions women as vulnerable population requiring intervention; relies heavily on single study as primary evidence source.
critical, often overlooked risk factor
major threat to women's health
crucial for proactive heart health management
significant driver of cardiovascular risk
more vulnerable
Counterarguments or limitations of the cited European Heart Journal study
Prevalence data comparing inflammation risk to traditional risk factors
Expert opinions questioning the clinical significance of inflammatory markers alone
Discussion of potential overdiagnosis or unnecessary treatment concerns
Perspectives from cardiologists on implementation challenges
Cost-effectiveness analysis of inflammation screening programs
Geopolitical Impact
🌎
This is a medical/health article about cardiovascular disease risk factors in women, not a geopolitical matter requiring international relations analysis.
Escalation Risk
low
Confidence
HIGH
Economic Lens
📈
Chronic inflammation identified as major heart disease risk factor in women could drive demand for diagnostic testing, anti-inflammatory treatments, and preventive healthcare services, expanding medical device and pharmaceutical markets.
Market Signal
bullish
Confidence
MED
Healthcare and Medical Services
Pharmaceutical Industry
Medical Devices and Diagnostics
Health Insurance
Wellness and Nutraceuticals
Fitness and Preventive Health Services
Women may increase spending on health screenings, inflammatory biomarker tests (hsCRP), preventive medications, anti-inflammatory supplements, and lifestyle modification services. Increased healthcare utilization could raise insurance premiums but improve long-term health outcomes and reduce catastrophic medical costs.
Governments may mandate inflammatory marker screening in women's health programs, expand insurance coverage for preventive cardiovascular testing, fund public awareness campaigns on inflammation risks, and incentivize development of anti-inflammatory therapeutics. Healthcare guidelines may be updated to include inflammation assessment in cardiovascular risk stratification.